Liver Transplantation for Acute Liver Injury in Asians Is More Likely Due to Herbal and Dietary Supplements.
Liver Transplantation for Acute Liver Injury in Asians Is More Likely Due to Herbal and Dietary Supplements.
复制标题
DOI:
10.1002/lt.26260
复制
发表时间:
2022-03
期刊:
影响因子:
--
通讯作者:
Odin JA
中科院分区:
文献类型:
--
作者:
Kesar V;Channen L;Masood U;Grewal P;Ahmad J;Roth NC;Odin JA
Drug induced liver injury (DILI) due to medications and herbal and dietary supplements (HDS) is a major cause of acute liver injury leading to liver transplantation (LT). This study used United Network for Organ Sharing LT data to analyze severe HDS induced acute liver injury in the United States. By convention, patients with acute DILI are listed as “Acute Hepatic Necrosis” (AHN) under the subheading “AHN: Drug Other Specify”. All patients waitlisted from 1994 to 2020 were divided into 3 subgroups: “HDS DILI”, “Non-HDS DILI”, and “AHN: unknown drug. Analyses were performed to identify epidemiologic differences between HDS DILI and Non-HDS DILI patients. Sub-analysis was performed for transplanted patients, including longitudinal changes. Of 1875 patients waitlisted for LT, 736 (39.2%) underwent LT. The proportion of Asian patients in the HDS DILI group was significantly higher compared to the non-HDS DILI group (17.4% v. 3.8%, p < 0.001). Excluding acetaminophen cases, the proportion of Black patients in the HDS DILI v. non-HDS group was significantly lower (8.7% v. 25.3%, p < 0.001). Waitlisted HDS DILI patients were significantly older (median age 38 y for HDS DILI vs 31 y for non-HDS DILI, p=0.03). Lastly, the number of patients requiring LT due to HDS DILI increased significantly over time with more than 70 % of cases occurring in the last 10 years (2010–2020) compared to the prior 15 years (1994–2009) (Ptrend =0.001). Ethnicity may help in identifying the cause of severe acute DILI, a growing problem as more patients experiment with HDS.
登录
查看更多内容
DOI:
10.1002/hep.31538
发表时间:
2021-06
期刊:
Hepatology (Baltimore, Md.)
影响因子:
--
作者:
Hoofnagle JH;Bonkovsky HL;Phillips EJ;Li YJ;Ahmad J;Barnhart H;Durazo F;Fontana RJ;Gu J;Khan I;Kleiner DE;Koh C;Rockey DC;Seeff LB;Serrano J;Stolz A;Tillmann HL;Vuppalanchi R;Navarro VJ;Drug-Induced Liver Injury Network
通讯作者:
Drug-Induced Liver Injury Network
影响因子:
12.6
作者:
Rossi, Simona;Navarro, Victor J.
通讯作者:
Navarro, Victor J.
影响因子:
4.6
作者:
Russo, MW;Galanko, JA;Watkins, P
通讯作者:
Watkins, P
影响因子:
158.5
作者:
EISENBERG, DM;KESSLER, RC;DELBANCO, TL
通讯作者:
DELBANCO, TL
影响因子:
29.4
作者:
Nicoletti P;Aithal GP;Bjornsson ES;Andrade RJ;Sawle A;Arrese M;Barnhart HX;Bondon-Guitton E;Hayashi PH;Bessone F;Carvajal A;Cascorbi I;Cirulli ET;Chalasani N;Conforti A;Coulthard SA;Daly MJ;Day CP;Dillon JF;Fontana RJ;Grove JI;Hallberg P;Hernández N;Ibáñez L;Kullak-Ublick GA;Laitinen T;Larrey D;Lucena MI;Maitland-van der Zee AH;Martin JH;Molokhia M;Pirmohamed M;Powell EE;Qin S;Serrano J;Stephens C;Stolz A;Wadelius M;Watkins PB;Floratos A;Shen Y;Nelson MR;Urban TJ;Daly AK;International Drug-Induced Liver Injury Consortium, Drug-Induced Liver Injury Network Investigators, and International Serious Adverse Events Consortium
通讯作者:
International Drug-Induced Liver Injury Consortium, Drug-Induced Liver Injury Network Investigators, and International Serious Adverse Events Consortium